1. 2013Jun27;95(12):doi: 10.1097/tp.0b013e318291a2da. “Treatment of knee osteoarthritis with autologous mesenchymal stem cells:a pilot study”
  2. Knee Surg Sports Traumatol Arthrosc.2013 Dec 11 “clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis”
  3. Rev Bras Hematol Hemoter.2013;35(5):352-357 “Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease:follow-up of up to 3 years”
  4. ExpLung Res.2013 Oct;39(8):315-27.doi:10.3109/01902148.2013.816803. “Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell.”
  5. 2007 Apr11;297(14):1568-76 “Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus”
  6. Clin Immunol.2013 Aug;148(2):186-97.doi:10.1016/j.clim.2013.05.014 “Hematopietic and mesenchymal stem cell transplantation for severe and refractory systemiclupus erythemaatosus.”
  7. Klin Med. 2011;89(5):44-9. “Late results of high-dose immunosuppressive therapy with autotransplantation of hematopoietec stem cells in patients with refractory SLE”
  8. Prochazka V, Gumulec J, Jaluvka F et al. Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant 2010; 19(11):1413-24.
  9. Walter DH, Krankenberg H, Balzer JO et al. Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circ Cardiovasc Interv 2011; 4(1):26-37.
  10. The paper, “Mesenchymal stem cells augment the adaptive response to eccentric exercise,” is in press and is available online or from the U. of I. News Bureau.